Novo targets more than five potential multi-blockbuster drugs by 2030; shares fall 8%

Verifying
  • Novo set ambitions to launch more than five potential multi-blockbuster drugs by 2030.
  • Shares fell 8% after Monday’s update.
  • Analysts said the update offered little new after shares tumbled for two years.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.